Jazz Pharma Q1 2025 Sales Dip
Ticker: JAZZ · Form: 10-Q · Filed: May 7, 2025 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | bearish |
Sentiment: bearish
Topics: earnings, revenue-decline, pharmaceuticals
TL;DR
Jazz Pharma Q1 sales down to $864.9M from $922.7M YoY. Watchlist.
AI Summary
Jazz Pharmaceuticals plc filed its 10-Q for the period ending March 31, 2025. The company reported net product sales of $854.4 million for the first quarter of 2025, a decrease from $911.8 million in the same period of 2024. Royalties and contract revenue also saw a slight decline from $10.9 million in Q1 2024 to $10.5 million in Q1 2025.
Why It Matters
This filing indicates a revenue decrease for Jazz Pharmaceuticals in early 2025, which could impact investor confidence and future growth projections.
Risk Assessment
Risk Level: medium — The decrease in product sales and royalties suggests potential market challenges or product lifecycle issues that could affect future financial performance.
Key Numbers
- $854.4M — Net Product Sales (Q1 2025 revenue, down from Q1 2024)
- $10.5M — Royalties and Contract Revenue (Q1 2025 revenue, down from Q1 2024)
- $864.9M — Total Revenue (Sum of product sales and royalties for Q1 2025)
- $922.7M — Total Revenue (Sum of product sales and royalties for Q1 2024)
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- $854.4 million (dollar_amount) — Net product sales for Q1 2025
- $911.8 million (dollar_amount) — Net product sales for Q1 2024
- $10.5 million (dollar_amount) — Royalties and contract revenue for Q1 2025
- $10.9 million (dollar_amount) — Royalties and contract revenue for Q1 2024
FAQ
What were Jazz Pharmaceuticals' net product sales for the first quarter of 2025?
Net product sales for the first quarter of 2025 were $854.4 million.
How do Q1 2025 net product sales compare to Q1 2024?
Net product sales decreased from $911.8 million in Q1 2024 to $854.4 million in Q1 2025.
What was the revenue from royalties and contract for Q1 2025?
Royalties and contract revenue for Q1 2025 amounted to $10.5 million.
Did royalties and contract revenue increase or decrease compared to Q1 2024?
Royalties and contract revenue decreased from $10.9 million in Q1 2024 to $10.5 million in Q1 2025.
What is the total revenue for Jazz Pharmaceuticals for the first quarter of 2025?
The total revenue for the first quarter of 2025, combining net product sales and royalties/contract revenue, is $864.9 million ($854.4M + $10.5M).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding Jazz Pharmaceuticals plc (JAZZ).